Tovedeso 7 mg tablete sa produljenim oslobađanjem
| Name | Tovedeso 7 mg tablete sa produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-862475317 |
| Active Substance | desfesoterodinsukcinat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 7 mg desfesoterodinsukcinata, što odgovara 5,2 mg desfesoterodina |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 10.02.2026 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/166 |
| Registration Number | 381-12-01/70-26-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD13 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
